Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas-Reference-Cited by-同舟云学术

Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas

Published:2007-01-06 Issue:2 Volume:14 Page:233-244
ISSN:1021-7770
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Chuu Jiunn-Jye,Liu Jacqueline Ming,Tsou Mei-Hua,Huang Chen-Lung,Chen Ching-Ping,Wang Hsin-Sheng,Chen Chiung-Tong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry, medical,Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://www.springerlink.com/index/pdf/10.1007/s11373-006-9141-3

Reference50 articles.

1. Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., Castagnetta L.A.,Epidemiology, risk factors, natural history of hepatocellular carcinoma. Ann. N. Y. Acad. Sci. 963:13–20 (2002)

2. El-Serag H.B.,Hepatocellular carcinoma: an epidemiologic view. J. Clin. Gastroenterol. 35(5 Suppl 2):S72–78 (2002)

3. Llovet J.M., Burroughs A., Bruix J., Hepatocellular carcinoma. Lancet 362:1907–1917 (2003)

4. Bosch F.X., Ribes J., Diaz M., Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5-S16. (2004)

5. Lee Y.T., Primary carcinoma of the liver: diagnosis, prognosis, and management. J. Surg. Oncol. 22:17–25 (1983)

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibronectin type III domain-containing protein 5 promotes autophagy via the AMPK/mTOR signaling pathway in hepatocellular carcinoma cells, contributing to nab-paclitaxel chemoresistance;Medical Oncology;2022-12-20

2. Fibronectin Type III Domain Containing 5 Contributes to Nab-paclitaxel Chemoresistance by Promoting Autophagy via the AMPK/mTOR Signaling Pathway in Hepatocellular Carcinoma Cells;2022-11-03

3. Small-molecule compounds target paraptosis to improve cancer therapy;Biomedicine & Pharmacotherapy;2019-10

4. Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma;Clinical Pharmacokinetics;2019-05-15

5. Hypoxia-inducible factor HIF-1α modulates drugs resistance in colon cancer cells;Revista de la Facultad de Medicina;2018-10-01